Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziding Feng

Showing results (61-70 of 288) with videos related to

Pageof 29
Sort By:
Cancer Epidemiology|August 27, 2013
Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosisSarah K Holt, Suzanne Kolb, Rong Fu, et al.
Clinical Chemistry|June 26, 2012
Biases introduced by choosing controls to match risk factors of cases in biomarker researchMargaret Sullivan Pepe, Jing Fan, Christopher W Seymour, et al.
Journal of the National Cancer Institute|November 9, 2023
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologiesRuth Etzioni, Roman Gulati, Christos Patriotis, et al.
Statistics in Medicine|February 2, 2021
The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curvesLeonidas E Bantis, John V Tsimikas, Gregory R Chambers, et al.
Clinical Chemistry|March 23, 2016
Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?Margaret S Pepe, Holly Janes, Christopher I Li, et al.
Biometrics|December 21, 2004
Evaluation of community-intervention trials via generalized linear mixed modelsYutaka Yasui, Ziding Feng, Paula Diehr, et al.
Urologic Oncology|May 4, 2012
The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingYuanyuan Liang, Donna P Ankerst, Ziding Feng, et al.
American Journal of Epidemiology|November 22, 2015
Toward Rigorous Data Harmonization in Cancer Epidemiology Research: One ApproachBetsy Rolland, Suzanna Reid, Deanna Stelling, et al.
Journal of Community Health|March 28, 2019
Community-Based Cervical Cancer Education: Changes in Knowledge and Beliefs Among Vietnamese American WomenCarolyn Y Fang, Minsun Lee, Ziding Feng, et al.
Gastroenterology|April 3, 2020
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium CohortHashem B El-Serag, Fasiha Kanwal, Ziding Feng, et al.
Pageof 29

Showing results (61-70 of 288) with videos related to

Sort By:
Pageof 29
Cancer Epidemiology|August 27, 2013
Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosisSarah K Holt, Suzanne Kolb, Rong Fu, et al.
Clinical Chemistry|June 26, 2012
Biases introduced by choosing controls to match risk factors of cases in biomarker researchMargaret Sullivan Pepe, Jing Fan, Christopher W Seymour, et al.
Journal of the National Cancer Institute|November 9, 2023
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologiesRuth Etzioni, Roman Gulati, Christos Patriotis, et al.
Statistics in Medicine|February 2, 2021
The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curvesLeonidas E Bantis, John V Tsimikas, Gregory R Chambers, et al.
Clinical Chemistry|March 23, 2016
Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?Margaret S Pepe, Holly Janes, Christopher I Li, et al.
Biometrics|December 21, 2004
Evaluation of community-intervention trials via generalized linear mixed modelsYutaka Yasui, Ziding Feng, Paula Diehr, et al.
Urologic Oncology|May 4, 2012
The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingYuanyuan Liang, Donna P Ankerst, Ziding Feng, et al.
American Journal of Epidemiology|November 22, 2015
Toward Rigorous Data Harmonization in Cancer Epidemiology Research: One ApproachBetsy Rolland, Suzanna Reid, Deanna Stelling, et al.
Journal of Community Health|March 28, 2019
Community-Based Cervical Cancer Education: Changes in Knowledge and Beliefs Among Vietnamese American WomenCarolyn Y Fang, Minsun Lee, Ziding Feng, et al.
Gastroenterology|April 3, 2020
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium CohortHashem B El-Serag, Fasiha Kanwal, Ziding Feng, et al.
Pageof 29